British Approved Names (BAN) 2022
- British Pharmacopoeia Commission
- TSO (The Stationery Office)
The British Approved Names 2022 is a British Pharmacopoeia publication. This new edition consolidates the drug names published in the British Approved Names 2017 with names published in its four Supplements, together with recommended International Nonproprietary Names (rINNs) adopted as new British Approved Names.
The British Approved Names (BAN) is the official dictionary of names for UK medicinal substances. British Approved Names are short, distinctive names for substances for which the systematic chemical or other scientific names are too complex for convenient general use. The BAN makes an important contribution to public health by ensuring that names selected are unique. The BAN is an essential reference for all individuals and organisations working within pharmaceutical research, manufacture and regulatory affairs.
156 new names added from supplements 1-4 of the BAN 2017
A number of revisions to existing material
Special attention to biological and biotechnological substances
Key to pronunciation, symbols and abbreviations
Guide to using the British Approved Names 2022
Cross-reference index of British Approved Names and Proprietary Names
Guidelines for pharmaceutical trademarks
Discontinued substances and products listed
As an alternative to the printed edition of BAN 2022, users of the British Pharmacopoeia (BP) 2022 can purchase a subscription to access the content online. More information on accessing BAN online can be found at www.pharmacopoeia.com.
|Availability||Not yet published: available to order||Delivery||Delivery options and charges|